Jon Birger Haug
About
In The Last Decade
Jon Birger Haug
19 papers receiving 353 citations
Peers
Comparison fields: 5 of 58
- Surgery 162
- Epidemiology 144
- Applied Microbiology and Biotechnology 91
- Gastroenterology 77
- Clinical Biochemistry 75
Countries citing papers authored by Jon Birger Haug
This map shows the geographic impact of Jon Birger Haug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Birger Haug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Birger Haug more than expected).
Fields of papers citing papers by Jon Birger Haug
This network shows the impact of papers produced by Jon Birger Haug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Birger Haug. The network helps show where Jon Birger Haug may publish in the future.
Co-authorship network of co-authors of Jon Birger Haug
This figure shows the co-authorship network connecting the top 25 collaborators of Jon Birger Haug. A scholar is included among the top collaborators of Jon Birger Haug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Birger Haug. Jon Birger Haug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 6 | |
| 5 | 14 | |
| 6 | 12 | |
| 7 | 11 | |
| 8 | 1 | |
| 9 | 12 | |
| 10 | 13 | |
| 11 | 17 | |
| 12 | 8 | |
| 13 | 1 | |
| 14 | Fornuftig bruk av antibiotika i sykehus | 2 |
| 15 | 20 | |
| 16 | 1 | |
| 17 | 26 | |
| 18 | A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study. | 28 |
| 19 | Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? | 71 |
| 20 | 106 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.